Home › Funds › PFM Health Sciences, LP › SPY

PFM Health Sciences, LP position in SPY

STATE STR SPDR S&P 500 ETF T

PFM Health Sciences, LP reported holding 32,421 shares of SPY (STATE STR SPDR S&P 500 ETF T) in its Q3 2026 13F filing — a position valued at US$24.7M, representing 2.53% of its reported portfolio and ranking #10 among its reported holdings. PFM Health Sciences, LP has disclosed SPY holdings in 4 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)32.42K sh
Reported value held$24.73M
Portfolio Weight2.53%
First reportedQ4 2024
Last changeNew
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How PFM Health Sciences, LP's SPY position evolved

PFM Health Sciences, LP first disclosed a stake in SPY in Q4 2024 at 12,427 shares (US$7.3M). The position peaked in Q3 2026 at 32,421 shares, worth US$24.7M. Across 4 filings, PFM Health Sciences, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 32,421 shares valued at US$24.7M.

Quarter by quarter

QuarterSharesValueChange
Q4 2024 12.43K $7.28M New
Q2 2025 17.13K $10.58M New
Q3 2025 21.21K $14.13M Add
Q3 2026 32.42K $24.73M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SPY and 13F data

SPY (STATE STR SPDR S&P 500 ETF T) is a company whose sector is not yet classified in our data. 27 other funds we track also report a position in SPY — the largest reported positions include JPMorgan Chase & Co (US$37.33B), Morgan Stanley (US$27.32B), Bank of America Corp (US$22.91B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SPY

All SPY fund holders →

FAQ

How long has PFM Health Sciences, LP held SPY?

PFM Health Sciences, LP has disclosed SPY holdings in 4 of the last 8 reported quarters, going back to Q4 2024.

What is PFM Health Sciences, LP's current position in SPY?

As of Q3 2026, PFM Health Sciences, LP holds 32.42K shares of SPY (STATE STR SPDR S&P 500 ETF T), valued at $24.73M, representing 2.53% of its reported portfolio and ranking #10.

Has PFM Health Sciences, LP been buying or selling SPY?

In the latest 13F filing (Q3 2026), PFM Health Sciences, LP newly opened its position in SPY. The position peaked in Q3 2026 at 32.42K shares.

Which other funds hold SPY?

Other major institutional holders of SPY include JPMorgan Chase & Co, Morgan Stanley, Bank of America Corp, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.